Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA.
Department of Acute and Tertiary Care, University of Pittsburgh School of Nursing, Pittsburgh, PA.
Transplantation. 2020 Mar;104(3):640-651. doi: 10.1097/TP.0000000000002872.
In a randomized controlled trial, lung transplant recipients (LTRs) using a mobile health intervention, Pocket Personal Assistant for Tracking Health (Pocket PATH), showed better adherence to the medical regimen than LTRs receiving usual care during the first year posttransplant. We examined whether these effects were maintained beyond the end of the trial and evaluated other potential risk factors for long-term nonadherence.
Adherence in 8 areas was evaluated at follow-up in separate LTR and family caregiver (collateral) assessments. Pocket PATH and usual care groups' nonadherence rates were compared; multivariable regression analyses then examined and controlled for other patient characteristics' associations with nonadherence.
One hundred five LTRs (75% of survivors) were assessed (M = 3.9 years posttransplant, SD = 0.8). Nonadherence rates in the past month were 23%-81% for self-care and lifestyle requirements (diet, exercise, blood pressure monitoring, spirometry), 13%-23% for immunosuppressants and other medications, and 4% for tobacco use, with 31% clinic appointment nonadherence in the past year. In multivariable analysis, the Pocket PATH group showed lower risk of nonadherence to lifestyle requirements (diet/exercise) than the usual care group (P < 0.05). Younger age and factors during the first year posttransplant (acute graft rejection, chronically elevated anxiety, less time rehospitalized, nonadherence at the final randomized controlled trial assessment) were each associated with nonadherence in at least 1 area at follow-up (P < 0.05).
Pocket PATH did not have sustained impact on most areas of the regimen, although we identified other risk factors for long-term nonadherence. Future work should explore strategies to facilitate sustained effects of mobile health interventions.
在一项随机对照试验中,使用移动健康干预措施“Pocket Personal Assistant for Tracking Health (Pocket PATH)”的肺移植受者(LTR)在移植后第一年的药物治疗依从性优于接受常规护理的 LTR。我们检查了这些效果是否在试验结束后仍能维持,并评估了长期不依从的其他潜在风险因素。
在随访时,通过单独的 LTR 和家庭照顾者(间接)评估来评估 8 个领域的依从性。比较 Pocket PATH 组和常规护理组的不依从率;然后进行多变量回归分析,以检查和控制其他患者特征与不依从的关联。
共评估了 105 名 LTR(幸存者的 75%)(M = 移植后 3.9 年,SD = 0.8)。过去一个月,自我护理和生活方式要求(饮食、运动、血压监测、肺活量测定)的不依从率为 23%-81%,免疫抑制剂和其他药物的不依从率为 13%-23%,烟草使用的不依从率为 4%,过去一年的诊所预约不依从率为 31%。在多变量分析中,Pocket PATH 组在生活方式要求(饮食/运动)方面的不依从风险低于常规护理组(P < 0.05)。年龄较小以及移植后第一年的因素(急性移植物排斥反应、慢性焦虑升高、再住院时间较短、最后一次随机对照试验评估时的不依从)与随访时至少 1 个领域的不依从相关(P < 0.05)。
尽管我们确定了长期不依从的其他风险因素,但 Pocket PATH 对治疗方案的大多数领域并没有持续的影响。未来的工作应该探索促进移动健康干预持续效果的策略。